Principia Wealth Advisory’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Principia Wealth Advisory's EW Position: Q3 2026 in Review
Principia Wealth Advisory increased its Edwards Lifesciences (EW) stake by 1.9% in Q3 2026, buying an estimated $89 and bringing the position to 55 shares worth $4.75K. The position accounts for ﹤0.01% of the portfolio, ranked #388.
Principia Wealth Advisory first reported a position in EW in Q4 2024 and has held it in 8 quarters since. The position peaked at $39.9K in Q3 2025. 1,345 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Principia Wealth Advisory held 55 shares of Edwards Lifesciences worth $4.75K as of Q3 2026.
- Principia Wealth Advisory bought 1 Edwards Lifesciences share in Q3 2026, an estimated $89.
- Edwards Lifesciences made up ﹤0.01% of Principia Wealth Advisory's portfolio in Q3 2026, its #388 holding.
- Principia Wealth Advisory first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 8 quarters since.
- Principia Wealth Advisory's Edwards Lifesciences position peaked at $39.9K in Q3 2025.
- 1,345 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Principia Wealth Advisory's 13F filing for Q3 2026, filed 12 Nov 2026.